[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Valeant Pharmaceuticals International Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

May 2018 | 35 pages | ID: V57529FE9CAEN
LNGAnalysis

US$ 200.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
“Valeant Pharmaceuticals International Inc Company Profile” is a detailed strategic and analytical report on Valeant Pharmaceuticals International Inc. The 2018 version of the report offers detailed insights into the company’s strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Valeant Pharmaceuticals International Inc.

Valeant Pharmaceuticals International Inc business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Valeant Pharmaceuticals International Inc are also analyzed.

Detailed SWOT Analysis of the company including key strengths and weaknesses of Valeant Pharmaceuticals International Inc, on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.

Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.

Financial analysis of Valeant Pharmaceuticals International Inc including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of the Valeant Pharmaceuticals International Inc and all latest updates of the company are provided. Further, M&A deals, expansion and asset purchase plans of the company are also detailed.

The 2018 version of the Valeant Pharmaceuticals International Inc report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION TO THE COMPANY

2.1 Valeant Pharmaceuticals International Inc- Key Findings
2.2 Valeant Pharmaceuticals International Inc- Geographic Locations
2.3 Valeant Pharmaceuticals International Inc- Subsidiaries and Affiliates
2.4 Valeant Pharmaceuticals International Inc- Business Divisions
2.5 Valeant Pharmaceuticals International Inc- Key Employees
  2.5.1 Management Team
  2.5.2 Board of Directors

3. VALEANT PHARMACEUTICALS INTERNATIONAL INC STRATEGIC ANALYSIS REVIEW

3.1 Valeant Pharmaceuticals International Inc- Key Strategies
3.2 Valeant Pharmaceuticals International Inc- Company Outlook Statement
3.3 Valeant Pharmaceuticals International Inc- SWOT Analysis
  3.3.1 Valeant Pharmaceuticals International Inc- Key Strengths
  3.3.2 Valeant Pharmaceuticals International Inc- Key Weaknesses
  3.3.3 Valeant Pharmaceuticals International Inc- Potential Opportunities
  3.3.4 Valeant Pharmaceuticals International Inc- Potential Threats
3.4 Valeant Pharmaceuticals International Inc- Key Competitors

4. BUSINESS DESCRIPTION OF THE COMPANY

4.1 Valeant Pharmaceuticals International Inc- Business Overview
4.2 Valeant Pharmaceuticals International Inc- Operations by Segment

5 PRODUCTS AND SERVICES DETAILS

5.1 Valeant Pharmaceuticals International Inc- Key Products
5.2 Valeant Pharmaceuticals International Inc- Key Service Areas
5.3 Valeant Pharmaceuticals International Inc- Key Brands

6 COMPANY DEVELOPMENTS

6.1 Valeant Pharmaceuticals International Inc- Company History
6.2 Valeant Pharmaceuticals International Inc- Latest Developments

7 FINANCIAL ANALYSIS

7.1 Valeant Pharmaceuticals International Inc- Income Statements
7.2 Valeant Pharmaceuticals International Inc- Balance Sheet
7.3 Valeant Pharmaceuticals International Inc- Cash Flow Statements

8 APPENDIX

8.1 About LNGAnalysis
8.2 Sources and Methodology
8.3 Contact Information


More Publications